Driehaus Capital Management LLC

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 938206 Chicago, IL

Position in KALV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,354,105

+$5,043,359 QoQ

Shares Held

564,039

+5.3% QoQ

Ownership

1.06%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#28

of 182 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 77.32532679477838.ToString("F0")% Shared 0.ToString("F0")% None 22.674673205221623.ToString("F0")%

Healthcare · as of Mar 31, 2026

Driehaus Capital Management LLC holds $3,010,622,183 across 56 Biotechnology names. KALV ranks #43 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	949,225	$305,830,802
2	XENE	Xenon Pharmaceuticals Inc.	4,491,653	$261,189,621
3	CRNX	Crinetics Pharmaceuticals, Inc.	6,395,922	$232,299,887
4	APGE	Apogee Therapeutics, Inc.	1,920,800	$161,673,736
5	EWTX	Edgewise Therapeutics, Inc.	4,477,942	$141,055,173
6	SYRE	Spyre Therapeutics, Inc.	2,790,785	$140,767,195
7	DFTX	Definium Therapeutics, Inc.	5,911,889	$111,734,702
8	SEPN	Septerna, Inc.	4,395,572	$105,625,595

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,354,105	564,039	+5.3%	Shares	Sole	2026-05-15
2024-06-30	$6,310,746	535,717	-1.1%	Shares	Sole	2024-08-15
2024-03-31	$6,422,640	541,538	-47.4%	Shares	Sole	2024-05-15
2023-12-31	$12,599,958	1,028,568	-0.6%	Shares	Sole	2024-02-14
2023-09-30	$9,963,419	1,034,623	-0.1%	Shares	Sole	2023-11-14
2023-06-30	$9,323,415	1,035,935	+2.1%	Shares	Sole	2023-08-14
2023-03-31	$7,978,835	1,015,119	+0.4%	Shares	Sole	2023-05-15
2022-12-31	$6,836,867	1,011,371	+91.0%	Shares	Sole	2023-02-14
2022-09-30	$7,682,159	529,439	+958.9%	Shares	Sole	2022-11-14
2020-12-31	$949,500	50,000	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.